Literature DB >> 10869318

Decreasing mortality from pulmonary embolism in the United States, 1979-1996.

D E Lilienfeld1.   

Abstract

BACKGROUND: Mortality trends and patterns for pulmonary embolism may yield clues to its aetiology. Previous investigations had identified several mortality contrasts in pulmonary embolism mortality among US residents. These findings had been made in the context of a trend of increasing rates during 1962-1984.
METHODS: Annual age-specific and age-adjusted pulmonary embolism mortality rates for US residents during 1979-1996 were compiled from the US National Center for Health Statistics web site. These data were analysed for mortality contrasts and trends.
RESULTS: For all racial-gender groups, age-adjusted mortality declined throughout the period. The greatest rate of decline was found among black men, followed by (in decreasing order) black women, white men, other men, white women, and other women. In 1996, the previously observed demographic contrasts of blacks experiencing the highest pulmonary embolism mortality, followed by whites and then others, and the male rate being higher than the female one were still present despite this decline. Age-specific mortality from pulmonary embolism in the US during 1996 also mirrored that reported for the 1970s, with mortality increasing during the life span (the risk of death doubling with each decade of life). Specifically, the annual age-adjusted pulmonary embolism mortality rate in 1996 for white men was 2.4 per 100 000 persons; white women, 2.3 per 100 000 persons; black men, 6.0 per 100 000 persons; black women, 4.8 per 100 000 persons; non-black non-white men, 1.0 per 100 000 persons; and non-black non-white women, 0.7 per 100 000 persons.
CONCLUSIONS: Mortality from pulmonary embolism in the US declined significantly during 1979-1996. Several demographic contrasts, particularly an excess among men, continue to exist.

Entities:  

Mesh:

Year:  2000        PMID: 10869318

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  18 in total

1.  Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany.

Authors:  Carolin Pütter; Olga von Beckerath; Hanna Maria Sobik; Holger Reinecke; Jürgen Stausberg; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

2.  The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality.

Authors:  Dona Schneider; David E Lilienfeld; Wansoo Im
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

3.  Incidence rate of pulmonary embolism in Germany: data from the federal statistical office.

Authors:  K Kröger; Ch Moerchel; Th Moysidis; F Santosa
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

4.  Anti-platelet and Anti-thrombotic Effects of a Poly-ingredient formulation: In vitro and in vivo experimental evidences.

Authors:  Mohamed Rafiq; Mohammed Azeemuddin
Journal:  Oman Med J       Date:  2012-11

Review 5.  Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism.

Authors:  Meredith Turetz; Andrew T Sideris; Oren A Friedman; Nidhi Triphathi; James M Horowitz
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

Review 6.  Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.

Authors:  Scott K Nagle; Mark L Schiebler; Michael D Repplinger; Christopher J François; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  Eur J Radiol       Date:  2015-12-29       Impact factor: 3.528

7.  Evaluation of the efficacy of venous thromboembolism prophylaxis guideline implementation in Japan.

Authors:  Kiyoaki Niimi; Masayoshi Kobayashi; Hiroshi Narita; Kiyohito Yamamoto; Kimihiro Komori
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

8.  Racial differences in 30-day mortality for pulmonary embolism.

Authors:  Said A Ibrahim; Roslyn A Stone; D Scott Obrosky; Jennifer Sartorius; Michael J Fine; Drahomir Aujesky
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

9.  Treatment of venous thromboembolism: guidelines translated for the clinician.

Authors:  M Houman Fekrazad; Renato D Lopes; Gregg J Stashenko; John H Alexander; David Garcia
Journal:  J Thromb Thrombolysis       Date:  2009-10       Impact factor: 2.300

10.  Effect of increasing doses of magnesium in experimental pulmonary hypertension after acute pulmonary embolism.

Authors:  Nikolaus A Haas; Jan Kemke; Ingram Schulze-Neick; Peter E Lange
Journal:  Intensive Care Med       Date:  2004-09-09       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.